Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPBAR1 | Q8TDU6 | 11/20 | 1.00 |
| ▸ | NR1H4 | Q96RI1 | 6/20 | 1.00 |
| ▸ | ABCB11 | O95342 | 5/20 | 1.00 |
| ▸ | ENPP2 | Q13822 | 3/20 | 1.00 |
| ▸ | SLC10A2 | Q12908 | 4/20 | 0.80 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.80 |
| ▸ | MEN1 | O00255 | 2/20 | 0.80 |
| ▸ | LMNA | P02545 | 1/20 | 0.80 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.80 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.80 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.80 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.80 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.80 |
| ▸ | SLC10A1 | Q14973 | 1/20 | 0.80 |
| ▸ | CISD1 | Q9NZ45 | 1/20 | 0.80 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.80 |
| ▸ | VDR | P11473 | 1/20 | 0.78 |
| ▸ | EPHA2 | P29317 | 1/20 | 0.78 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.76 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.75 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Glycoursodeoxycholic Acid SCHEMBL20204267 | 1.00 | GPBAR1 (1.00) | GPBAR1NR1H4ABCB11ENPP2SLC10A2 | |
| Glycoursodeoxycholic Acid SCHEMBL13851608 | 1.00 | GPBAR1 (1.00) | GPBAR1NR1H4ABCB11ENPP2SLC10A2 | |
| Glycoursodeoxycholic Acid SCHEMBL11962429 | 1.00 | GPBAR1 (1.00) | GPBAR1NR1H4ABCB11ENPP2SLC10A2 | |
| Glycoursodeoxycholic Acid SCHEMBL28793575 | 1.00 | GPBAR1 (1.00) | GPBAR1NR1H4ABCB11ENPP2SLC10A2 | |
| Glycoursodeoxycholic Acid SCHEMBL9151495 | 1.00 | GPBAR1 (1.00) | GPBAR1NR1H4ABCB11ENPP2SLC10A2 | |
| Glycoursodeoxycholic Acid SCHEMBL12917601 | 1.00 | GPBAR1 (1.00) | GPBAR1NR1H4ABCB11ENPP2SLC10A2 | |
| Glycochenodeoxycholate SCHEMBL236354 | 1.00 | GPBAR1 (1.00) | GPBAR1NR1H4ABCB11ENPP2SLC10A2 | |
| Glycoursodeoxycholic Acid SCHEMBL935341 | 1.00 | GPBAR1 (1.00) | GPBAR1NR1H4ABCB11ENPP2SLC10A2 | |
| Glycoursodeoxycholic Acid SCHEMBL10694925 | 1.00 | GPBAR1 (1.00) | GPBAR1NR1H4ABCB11ENPP2SLC10A2 | |
| Glycoursodeoxycholic Acid SCHEMBL1219678 | 1.00 | GPBAR1 (1.00) | GPBAR1NR1H4ABCB11ENPP2SLC10A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3943 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4747627-A1 | METHODS AND SYSTEMS FOR PREDICTIVE CLASSIFICATION BY MASS SPECTROMETRY AND TRAINED LARGE SPECTRAL MODELS | Matterworks Inc (US) | 2026-05-27 | — | — | EP | claimed |
| CN-122075506-A | Soluble powder and application thereof in treating avian coccidiosis | — | 2026-05-26 | — | — | CN | claimed |
| CN-122056828-A | Industrial preparation method of vitamin K1 micelle injection preparation | 浙江创新生物有限公司 | 2026-05-19 | — | — | CN | claimed |
| CN-122070276-A | Prodrugs of xanomeline, prodrugs of trospium chloride and methods of using the same | 人类生物科学股份有限公司 | 2026-05-19 | — | — | CN | claimed |
| EP-3869192-B1 | METHOD FOR QUANTITATIVE DETECTION OF VARIOUS METABOLITES IN BIOLOGICAL SAMPLE | HUMAN METABOLOMICS INST INC (CN) | 2026-05-13 | — | — | EP | claimed |
| CN-122017068-A | Bile acid high-flux detection method based on ultra-high performance liquid chromatography tandem mass spectrometry and application thereof | 青岛百谱生物科技有限公司 | 2026-05-12 | — | — | CN | claimed |
| EP-4705289-A1 | PRODRUGS OF XANOMELINE, PRODRUGS OF TROSPIUM AND METHODS OF USE THEREOF | Terran Biosciences Inc. (US) | 2026-03-11 | — | — | EP | claimed |
| US-12569502-B2 | Use of bile acids and derivatives thereof in preparation of GPR39 agonist | PEKING UNIVERSITY (CN) | 2026-03-10 | — | — | US | claimed |
| CN-121577901-A | Urine metabolism marker combination for distinguishing benign kidney diseases from kidney cancers and application thereof | 哈尔滨脉图精准技术有限公司 | 2026-02-27 | — | — | CN | claimed |
| EP-4262876-B1 | COVALENTLY MODIFIED ANTIGENS FOR IMPROVED IMMUNE RESPONSE AND/OR STABILITY | DEFENCE THERAPEUTICS INC (CA) | 2026-02-25 | — | — | EP | claimed |
| EP-0813421-A1 | LIQUID FORMULATIONS FOR PROTEINIC PHARMACEUTICALS COMPRISING AT LEAST 2 ABSORPTION ENHANCERS | MODI, Pankaj (CA) | 1997-12-29 | — | — | EP | claimed |
| EP-0799030-A1 | POWDER FORMULATIONS CONTAINING MELEZITOSE AS A DILUENT | Astra Aktiebolag (SE) | 1997-10-08 | — | — | EP | claimed |
| US-5653987-A | FOR ORAL DELIVERY OF INSULIN | MODI PANKAJ (CA) | 1997-08-05 | — | — | US | claimed |
| WO-1996036352-A1 | LIQUID FORMULATIONS FOR PROTEINIC PHARMACEUTICALS COMPRISING AT LEAST 2 ABSORPTION ENHANCERS | MODI PANKAJ (CA) | 1996-11-21 | — | — | WO | claimed |
| WO-1996019207-A1 | POWDER FORMULATIONS CONTAINING MELEZITOSE AS A DILUENT | ASTRA AKTIEBOLAG (SE) | 1996-06-27 | — | — | WO | claimed |
| US-5010056-A | Growth disorders | PIERREL SPA (IT) | 1991-04-23 | — | — | US | claimed |
| EP-0301392-A1 | Pharmaceutical composition for intranasal administration comprising GH - Releasing hormone, a cholinergic agonist and in case a bile salt | Pierrel S.p.A. (IT) | 1989-02-01 | — | — | EP | claimed |
| EP-0273469-A1 | Oral pharmaceutical compositions with sustained release | Gipharmex S.p.A. (IT) | 1988-07-06 | — | — | EP | claimed |
| US-4164573-A | INSULIN | GALINSKY ALVIN M | 1979-08-14 | — | — | US | claimed |
| US-4158707-A | Parenteral preparations | HOFFMANN-LA ROCHE INC. (US) | 1979-06-19 | — | — | US | claimed |